3. 10. 2024 | Natalie Bezděková

0

• Share with others    

Prague, 1 October 2024 – Tomáš Čupr, the well-known Czech entrepreneur and founder of Rohlik, is actively involved in the restructuring of Pilulka through his manager Peter Klekner, whom he has appointed as interim CEO. Klekner, who now heads the investment group TCF Capital, will be tasked with stabilising Pilulka and overcoming its current problems.

Peter Klekner, the newly appointed Interim CEO, has also been appointed as the proxy of Pilulka Pharmacies from 1 October 2024. Brothers Peter and Martin Kas, Pilulka’s founders and major shareholders, who have long been part of its management, have decided to withdraw from active management of the company. However, they remain on the board of directors, where they will continue to be involved in strategic decisions.

“According to the latest information published by Pilulka, the company’s situation is much more complicated than we originally thought at the time I gave the company a financial injection. My active participation in the restructuring together with the TCF Capital team is now essential. We will work to reverse the adverse developments and protect not only our investment, but also the thousands of small shareholders who have placed their trust in Pilulka. Based on the agreement with the Board of Directors, I have therefore put one of my most experienced managers, Peter Klekner, in charge of the company,” said Tomáš Čupr.

Peter Klekner comes to Pilulka with a wealth of experience gained during a career spanning more than ten years in senior positions in various sectors. In addition to leading the Hungarian branch of Rohlik, he has held senior positions at companies such as L’Oréal, where he led the cosmetics giant, and Philips, where he was involved in digitalization and process transformation. His experience in FMCG, e-commerce and business transformation makes him the ideal candidate for this challenging role.

Tomáš Čupr chose Peter Klekner as a director of his investment company TCF Capital last year precisely because of his ability to manage complex processes and lead companies to sustainable expansion. He is now tasked with stabilising Pilulka, which is struggling with falling sales and rising costs. The move is part of TCF Capital’s broader strategy, which includes heavy involvement in the operational management of the companies it invests in.

The future of Pilulka will depend on how it manages to get the company back on its feet and set it on a sustainable growth path. Klekner is expected to focus on optimizing internal processes, improving financial results and strengthening Pilulka’s market position.

Photo source: TCF Capital

Natalie Bezděková

I am a student of Master's degree in Political Science. I am interested in marketing, especially copywriting and social media. I also focus on political and social events at home and abroad and technological innovations. My free time is filled with sports, reading and a passion for travel.